Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance

Direxion Daily FTSE China Bull 3x SharesTrade

Price performance (Past 24H)

Key statistics

Alcon AG vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Alcon AG trades at $73.8 (market cap $36.44B), while Direxion Daily FTSE China Bull 3x Shares trades at $28.94. The key difference: Alcon AG pays a 0.48% dividend while Direxion Daily FTSE China Bull 3x Shares pays none, and Alcon AG is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.

ALCYINN
Market Cap
$36.44B
Sector
HealthLeveraged / Inverse
52-Week High
$90.12$56.62
52-Week Low
$62.02$21.45
Enterprise Value
$40.28B
Dividend Yield
0.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alcon AG

ALC trades at $73.525, down 0.14% on the day, with a bullish technical signal from moving averages and positive analyst sentiment. Recent Q2 2026 earnings beat estimates, with revenue of $10.4 billion in 2025 and a net income margin of 5.92%. The company raised its 2026 profitability outlook, citing tariff relief and strong product launches.

The stock offers a 17.9% upside to the consensus price target of $86.67, supported by bullish analyst ratings and improving cash flow trends. Key risks include elevated P/E valuation at 57.52 and potential macroeconomic pressures on medical device demand. Earnings growth and execution on new products remain critical for sustained momentum.

Direxion Daily FTSE China Bull 3x Shares

YINN, a leveraged ETF tracking the FTSE China Bull 3x strategy, trades at $28.93, down 10.43% in 24 hours amid broad bearish technical signals. The fund lacks traditional financial ratios due to its structure, with a dividend of $0.21 scheduled for June 2026. Recent news highlights China's economic stimulus and AI investments, but geopolitical tensions and regulatory risks persist.

Outlook remains cautious due to leverage amplifying volatility; opportunities exist if Chinese equities rebound, but risks include US-China friction and economic slowdowns. Investors should weigh the ETF's high-risk profile against potential gains from China's tech growth initiatives.

Returns comparison

Trailing returns across standard periods

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Direxion Daily FTSE China Bull 3x Shares

YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.

Read more on YINN